BACKGROUND: Hidradenitis suppurativa (HS) is a chronic relapsing inftarnrnatory disease ofterminal hair follicles with a profound impact on the patient's daily life, probably one ofthe worst that has been analyzed and evaluated in dermatology. The aim ofthis study was to evaluate the QoL impairment in HS and identify the factors that inftuence it. METHODS: The study was conducted with a group of forty-two patients affected by HS, aged 10-62 years, referred to the HS consultation service ofDermatology Clinic ofTor Vergata. Ali patients filled out the Dermatology Life Quality Index (DLQI questionnaire). The DLQI questions are categorized into six heading items: symptoms and feelings, daily activities, leisure, personal relationships, work and school, and treatment. The severity of the HS disease was evaluated with the Hurley staging classification, the modified Sartorius score and the Acne Inversa Severity Index (AlSI Score). A Visual Analog Scale was used for pain (PAlN VAS). Patients were divided into three groups according to AISI Index Score: mild (4 male, 8 female), moderate (2 male, 9 female) and severe patients (6 male, 13 female). RESULTS: Our findings are in agreement with existing literature who claims that patients with HS have a significant impairment in QoL, expressed by high DLQI Score (12.6±8). The most compromised elements were clinical symptoms (1.60), feelings (1.64) and daily activities (1.71). The clinical stage of disease is the most important factor related to the DLQI. The significant positive correlation between the AISI scores and DLQI scores (Pearson's r =0.53) confirms disease severity as a predictor of worsening QoL. Pain, discomfort and embarrassment are al so involved. Presence ofhigher PAlN VAS Score was associated with an increase in DLQI (Pearson's r =0.6). QoL was affected by age: between 26 and 49 years, an increase ofthe DLQI values is observed; moreover, in this group ofpatients, HS is a limitation for studying and work activities much more than in the other categories. In patients with severe forms, the choice ofthe clothes to wear is an important cause of discomfort. This study does not reveal a correlation between disease severity and impact on sex life. CONCLUSIONS: HS is a profoundly debilitating disease which affects patient' lives physically, emotionally and psychologically. The average recorded ofthe DLQI Score is higher than those found in other chronic dermatologic conditions traditionally regarded as causing significant disability. For this reason, the need to measure the quality of life of HS patients becomes particularly significant, and therefore it could be helpful to design a new evaluation method or a score able to specifically monitor the HS impact on QoL and to evidence clearly aspects already overlooked.
Franceschini, C., Caposiena, D., Faleri, S., Chiricozzi, A., Rossi, P., Bianchi, L. (2016). Quality-of-life impairment in hidradenitis suppurativa. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 151(2 suppl 2), 37-43.
Quality-of-life impairment in hidradenitis suppurativa
CHIRICOZZI, ANDREA;ROSSI, PIERO;BIANCHI, LUCA
2016-01-01
Abstract
BACKGROUND: Hidradenitis suppurativa (HS) is a chronic relapsing inftarnrnatory disease ofterminal hair follicles with a profound impact on the patient's daily life, probably one ofthe worst that has been analyzed and evaluated in dermatology. The aim ofthis study was to evaluate the QoL impairment in HS and identify the factors that inftuence it. METHODS: The study was conducted with a group of forty-two patients affected by HS, aged 10-62 years, referred to the HS consultation service ofDermatology Clinic ofTor Vergata. Ali patients filled out the Dermatology Life Quality Index (DLQI questionnaire). The DLQI questions are categorized into six heading items: symptoms and feelings, daily activities, leisure, personal relationships, work and school, and treatment. The severity of the HS disease was evaluated with the Hurley staging classification, the modified Sartorius score and the Acne Inversa Severity Index (AlSI Score). A Visual Analog Scale was used for pain (PAlN VAS). Patients were divided into three groups according to AISI Index Score: mild (4 male, 8 female), moderate (2 male, 9 female) and severe patients (6 male, 13 female). RESULTS: Our findings are in agreement with existing literature who claims that patients with HS have a significant impairment in QoL, expressed by high DLQI Score (12.6±8). The most compromised elements were clinical symptoms (1.60), feelings (1.64) and daily activities (1.71). The clinical stage of disease is the most important factor related to the DLQI. The significant positive correlation between the AISI scores and DLQI scores (Pearson's r =0.53) confirms disease severity as a predictor of worsening QoL. Pain, discomfort and embarrassment are al so involved. Presence ofhigher PAlN VAS Score was associated with an increase in DLQI (Pearson's r =0.6). QoL was affected by age: between 26 and 49 years, an increase ofthe DLQI values is observed; moreover, in this group ofpatients, HS is a limitation for studying and work activities much more than in the other categories. In patients with severe forms, the choice ofthe clothes to wear is an important cause of discomfort. This study does not reveal a correlation between disease severity and impact on sex life. CONCLUSIONS: HS is a profoundly debilitating disease which affects patient' lives physically, emotionally and psychologically. The average recorded ofthe DLQI Score is higher than those found in other chronic dermatologic conditions traditionally regarded as causing significant disability. For this reason, the need to measure the quality of life of HS patients becomes particularly significant, and therefore it could be helpful to design a new evaluation method or a score able to specifically monitor the HS impact on QoL and to evidence clearly aspects already overlooked.File | Dimensione | Formato | |
---|---|---|---|
QoL impairment in hidradenitis suppurativa.pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
5.21 MB
Formato
Adobe PDF
|
5.21 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.